#read

c-LEcta inducted into the "Biotech Hall of Fame"

BIO Deutschland’s Biotech Hall of Fame has welcomed two more companies. c-LEcta and Proteros Biostructures, two German biotechnology companies whose business models represent different areas of application within the sector, have been inducted. c-LEcta develops enzymes for industrial processes and supplies companies in the food and pharmaceutical sectors in more than 40 countries. Proteros Biostructures operates in the field of drug discovery and protein analytics. The company supports pharmaceutical and biotechnology firms in identifying new drug candidates and, according to its own figures, collaborates with more than 200 partners in Europe, the USA and Japan.

03/06/2026

According to BIO Deutschland, both companies illustrate the breadth of biotechnological platform technologies, ranging from industrial applications to drug development. At the same time, the industry association highlights their contribution to the key priorities of Germany’s High-Tech Agenda in the fields of health research and agricultural and food systems. The Hall of Fame showcases companies that were often founded as start-ups or spin-offs and have successfully brought their technologies to market. With this latest addition, the list now comprises 15 German biotechnology companies. Earlier companies such as AiCuris and MorphoSys also remain documented in the Hall of Fame as part of the history of German biotechnology.

Press release from “BIO Deutschland e.V.” dated 3 June 2026

The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.

Click here to access the original content